
Imperio Pharma LLP
About Imperio Pharma LLP
Data last updated:
Imperio Pharma LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 June 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAX-5556.
The LLP has a total obligation of contribution of βΉ50,000. It is led by designated partners Majid Sajid Paithankar and Maheboob Abdul Raheman Paithankar.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at H. No. 1002/A Hanuman Ali Tal Murbad Thane, Maharashtra, India β 421401.
Court records list 2 cases involving the LLP, including 2 filed by the LLP; 1 case is pending.
Imperio Pharma LLP is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-33-0191990).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. 1002/A Hanuman Ali Tal Murbad Thane, Maharashtra, India β 421401
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Imperio Pharma LLP
Imperio Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Majid Sajid Paithankar Also directs: P&S Builders & Developers LLP | Designated Partner | 28 Jun 2021 | 5 Years 3 Months | Current |
| Maheboob Abdul Raheman Paithankar Also directs: P&S Builders & Developers LLP | Designated Partner | 28 Jun 2021 | 5 Years 3 Months | Current |
Financials of Imperio Pharma LLP FY 2025 filings available
Financial Statement Summary of Imperio Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Imperio Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Imperio Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Imperio Pharma LLP
Imperio Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Imperio Pharma LLP
Employment history and EPFO contributions of people linked to Imperio Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Imperio Pharma LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Imperio Pharma LLP
Imperio Pharma LLP has 2 court cases on record: 2 filed by Imperio Pharma. 1 case is pending and 1 is disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Maharashtra Pharmaceutical Drugs and Cosmetic Udyog Kamgar Sangathana | Pending |
| District court, Thane, Maharashtra | Court case (M.C.A.) | Filed by the company against Maharashtra Pharmaceutical Drugs and Cosmetic | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Imperio Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Imperio Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Imperio Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Imperio Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Imperio Pharma LLP
Frequently Asked Questions about Imperio Pharma LLP
Imperio Pharma is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 28 June 2021 (5+ years old) and is registered under LLPIN AAX-5556.
Imperio Pharma has 2 current designated partners:
- Majid Sajid Paithankar - Designated Partner
- Maheboob Abdul Raheman Paithankar - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Imperio Pharma is AAX-5556. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Imperio Pharma has 2 court cases on record: 2 filed by the LLP. 1 is pending. Most are in the high courts.
Imperio Pharma was incorporated on 28 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Yes, Imperio Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-33-0191990).
The registered office of Imperio Pharma is at H. No. 1002A Hanuman Ali Tal Murbad Thane, Maharashtra, India β 421401.
The total obligation of contribution is βΉ50,000.
Imperio Pharma operates in the pharma industry, in the drug formulation and development segment.